2024 KSoLA Update on New Lipid-Lowering Agents: Inclisiran and Bempedoic Acid
Inclisiran and bempedoic acid (BA) are non-statin lipid-lowering agents that have been approved for use in the US and Europe. Inclisiran, a subcutaneously administered small interfering RNA targeting proprotein convertase subtilisin/kexin type 9 messenger RNA, is effectively delivered to the liver v...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Korean Society of Lipid and Atherosclerosis
2025-05-01
|
| Sarja: | Journal of Lipid and Atherosclerosis |
| Aiheet: | |
| Linkit: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2025.14.2.135&code=9992JLA&vmode=FULL |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|